Drawing for CITY-LABS YOUR HEALTH YOUR TIME YOUR PLACE

USPTO serial 79271634

CITY-LABS YOUR HEALTH YOUR TIME YOUR PLACE

Reviewed by CopyMark Law Group

Reg. 6191995Status 700Renewal
Filing date
Status date
Registration date
Nov 10, 2020
Examiner
MAHMOUDI, MARIAM AZIZ
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CITY-LABS YOUR HEALTH YOUR TIME YOUR PLACE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $975

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Boris Umansky

Boris Umansky Ladas & Parry LLP224 S. Michigan Ave., Ste. 1600Chicago, IL 60604UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
041Training in the field of medicine, laboratory medicine and clinical biologyACTIVE—
042Analytical laboratory services, namely, laboratory analysis services in the fields of laboratory medicine, clinical biology, primary care and integrated care; DNA testing laboratory services for paternity tests; preparation of biological samples for testing and analysis in research laboratories for scientific and research purposesACTIVE—
044Medical services, namely, the removal, treatment and processing of bone marrow; medical services, namely, the removal, treatment and processing of stem cells; medical services, namely, the removal, treatment and processing of human cells; medical services, namely, the removal, treatment and processing of human blood; medical services, namely, the removal, treatment and processing of umbilical cord blood; medical tests for diagnostic or treatment purposes; medical testing of serum for diagnostic or treatment purposes; Medical and health care services, namely, DNA, genetics and genetic testing for medical purposes ; medical testing, namely, assessments of physical fitness; medical laboratory services for the analysis of samples taken from patients; medical laboratory services for the analysis of blood samples taken from patients; medical analysis services provided by medical laboratories for diagnostic and therapeutic purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 10, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Sep 8, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 28, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 20, 2021XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Feb 20, 2021XXCRGENERIC MADRID TRANSACTION CREATED—
Feb 10, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 10, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 25, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 25, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 5, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 21, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 20, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 19, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 19, 2020ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
May 4, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
May 4, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 4, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 11, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 10, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 10, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 24, 2020RFNTREFUSAL PROCESSED BY IB—
Jan 7, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 7, 2020RFRRREFUSAL PROCESSED BY MPU—
Dec 10, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 9, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 3, 2019DOCKASSIGNED TO EXAMINER—
Nov 19, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 15, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 14, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance